Table 2: Statistics of female NGS panel results.
Mutant gene |
Mutation frequency |
Related diseases |
Genetic model |
ZP2 |
4 |
Oocyte maturation defect |
AR |
TUBB8 |
2 |
Oocyte maturation defect |
AD/AR |
WEE2 |
2 |
Oocyte maturation defect |
AR |
ZP3 |
1 |
Oocyte maturation defect |
AD |
PANX1 |
1 |
Oocyte maturation defect type 7 |
AD |
IL17RD |
3 |
Hypogonadotropic hypogonadism |
AD/AR |
PROKR2 |
2 |
Hypogonadotropic hypogonadism |
AD |
KAL1 |
2 |
Hypogonadotropic hypogonadism |
XLR |
SPRY4 |
1 |
Hypogonadotropic hypogonadism |
AD |
GNRHR |
1 |
Hypogonadotropic hypogonadism |
AR |
HS6ST1 |
1 |
Hypogonadotropic hypogonadism type 15 with or without anosmia |
AD |
GDF9 |
4 |
Premature ovarian failure |
AR |
ERCC6 |
3 |
Premature ovarian failure |
AD |
HFM1 |
1 |
Premature ovarian failure |
AR |
EIF2B2 |
1 |
Premature ovarian failure |
AR |
FMR1 |
1 |
Premature ovarian failure |
XL |
DIAPH2 |
1 |
Premature ovarian failure |
XLD |
PSMC3IP |
1 |
Ovarian dysgenesis |
AR |
MCM9 |
1 |
Ovarian dysgenesis |
AR |
NUP 107 |
1 |
Ovarian dysgenesis type 6 |
AR |
POR |
2 |
Cytochrome P450 oxidoreductase deficiency |
AR |
TLE6 |
1 |
Preimplantation embryonic lethality |
AR |
PADI6 |
1 |
Preimplantation embryonic lethality |
AR |
LHCGR |
1 |
Luteinizing hormone resistance |
AR |
BMP15 |
1 |
Premature ovarian failure 4/Ovarian dysgenesis 2 |
XL |
AD: Autosomal Dominance; AR: Autosomal Recessive; XLD: X Linked Dominance; XLR: X-Linked Recessive